A detailed history of Caprock Group, Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Caprock Group, Inc. holds 2,666 shares of DGX stock, worth $365,481. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,666
Previous 2,704 1.41%
Holding current value
$365,481
Previous $372,000 4.84%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$123.78 - $142.11 $4,703 - $5,400
-38 Reduced 1.41%
2,666 $354,000
Q4 2023

Jan 18, 2024

SELL
$120.62 - $141.12 $964 - $1,128
-8 Reduced 0.29%
2,704 $372,000
Q3 2023

Oct 18, 2023

SELL
$121.86 - $144.92 $9,383 - $11,158
-77 Reduced 2.76%
2,712 $330,000
Q2 2023

Aug 10, 2023

SELL
$130.56 - $146.84 $43,215 - $48,604
-331 Reduced 10.61%
2,789 $392,000
Q1 2023

Apr 26, 2023

BUY
$131.53 - $155.76 $1,052 - $1,246
8 Added 0.26%
3,120 $441,000
Q4 2022

Jan 23, 2023

SELL
$123.31 - $157.26 $242,797 - $309,644
-1,969 Reduced 38.75%
3,112 $0
Q3 2022

Nov 07, 2022

SELL
$121.77 - $141.1 $6,819 - $7,901
-56 Reduced 1.09%
5,081 $623,000
Q2 2022

Jul 26, 2022

BUY
$127.07 - $145.39 $249,565 - $285,545
1,964 Added 61.9%
5,137 $683,000
Q1 2022

Apr 12, 2022

BUY
$129.09 - $164.35 $4,647 - $5,916
36 Added 1.15%
3,173 $434,000
Q4 2021

Jan 18, 2022

BUY
$140.36 - $173.01 $842 - $1,038
6 Added 0.19%
3,137 $543,000
Q3 2021

Oct 07, 2021

BUY
$132.95 - $158.0 $14,624 - $17,380
110 Added 3.64%
3,131 $455,000
Q2 2021

Aug 13, 2021

SELL
$126.66 - $141.48 $24,698 - $27,588
-195 Reduced 6.06%
3,021 $399,000
Q1 2021

Apr 29, 2021

BUY
$114.63 - $133.34 $368,650 - $428,821
3,216 New
3,216 $413,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Caprock Group, Inc. Portfolio

Follow Caprock Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.